Clinical Trial Update: Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chromium's effects on insulin and vascular function in people at risk for diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose
• Impaired Glucose Tolerance
• Insulin Resistance
• Obesity
• Prediabetes

Drugs mentioned

• Chromium (Chromium)

Snippet

Sponsor: Griffin Hospital | Conditions: Obesity, Pre-diabetes | Phase 2 | Status: COMPLETED